HIGH LEVELS OF CIRCULATING PLASMA CELLS ARE AN INDEPENDENT HIGH-RISK FEATURE IN MULTIPLE MYELOMA PATIENTS AND THEIR PROGNOSTIC IMPACT IS MODULATED BY THE ACHIEVEMENT OF MINIMAL RESIDUAL DISEASE NEGATIVITY

被引：0
|
作者：
Bertamini, L. [1 ]
Stefanoni, P. [1 ]
Tacchetti, P. [1 ]
Ledda, A. [1 ]
Palmas, A. [1 ]
Gentile, M. [1 ]
Palmieri, S. [1 ]
Annibali, O. [1 ]
Musolino, C. [1 ]
Burdisso, M. [1 ]
Capra, A. [1 ]
Rizzi, R. [1 ]
Molica, S. [1 ]
Cellini, C. [1 ]
Monaco, F. [1 ]
De Sabbata, G. [1 ]
Cea, M. [1 ]
Rivolti, E. [1 ]
Fazio, F. [1 ]
Musto, P. [1 ]
Boccadoro, M. [1 ]
Gay, F. [1 ]
机构：
[1] European Myeloma Network, Turin, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C008
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [1] Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity
    Bertamini, Luca
    Grasso, Mariella
    D'Agostino, Mattia
    Pascarella, Anna
    Tosi, Patrizia
    Monaco, Federico
    Pisani, Francesco
    Bertazzoni, Paola
    Gilestro, Milena
    Capra, Andrea
    Galieni, Piero
    Annibali, Ombretta
    Pavone, Vincenzo
    Molica, Stefano
    Ronconi, Sonia
    Tacchetti, Paola
    Musto, Pellegrino
    Gay, Francesca
    Boccadoro, Mario
    Oliva, Stefania
    BLOOD, 2020, 136
  • [2] Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma
    Mohan, Meera
    Szabo, Aniko
    Yarlagadda, Naveen
    Gundarlapalli, Sravani
    Thanendrarajan, Sharmilan
    Kendrick, Samantha
    Schinke, Carolina
    Alapat, Daisy
    Sawyer, Jeffrey
    Tian, Erming
    Tricot, Guido
    van Rhee, Frits
    Zangari, Maurizio
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : E341 - E344
  • [3] Impact of Minimal Residual Disease in High and Standard Risk Multiple Myeloma
    Schinke, Carolina
    Deshpande, Shayu
    Mitchell, Alan
    Faham, Malek
    Patel, Purvi
    Thanendrarajan, Sharmilan
    Mohan, Meera
    Mathur, Pankaj
    Matin, Aasiya
    Radhakrishnar, Muthukumar
    Tytarenko, Ruslana
    Stephens, Owen W.
    van Rhee, Frits
    Zangari, Maurizio
    Jethava, Yogesh
    Petty, Nathan
    Alapat, Daisy V.
    Johnson, Sarah K.
    Epstein, Joshua
    Barlogie, Bart
    Davies, Faith E.
    Heuck, Christoph
    Hoering, Antje
    Weinhold, Niels
    Morgan, Gareth J.
    BLOOD, 2015, 126 (23)
  • [4] Correlation of minimal residual disease negativity (MRD-) with prognosis in high-risk myeloma (HRM).
    Kunacheewa, Chutima
    Patel, Krina K.
    Lee, Hans Chulhee
    Thomas, Sheeba K.
    Amini, Behrang
    Srour, Samer
    Bashir, Qaiser
    Qazilbash, Muzaffar H.
    Weber, Donna M.
    Neelapu, Sattva Swarup
    Orlowski, Robert Z.
    Feng, Lei
    Lin, Pei
    Manasanch, Elisabet Esteve
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Increased Circulating Plasma Cells On Multiparametric Flow Cytometry As An Independent Prognostic Biomarker In Newly Diagnosed Multiple Myeloma: Implications For Redefining High-Risk Myeloma
    Gonsalves, Wilson I.
    Gupta, Vinay
    Rajkumar, S. Vincent
    Morice, William G.
    Timm, Michael M.
    Singh, Preet Paul
    Dispenzieri, Angela
    Buadi, Francis K.
    Lacy, Martha Q.
    Kapoor, Prashant
    Gertz, Morie A.
    Kumar, Shaji K.
    BLOOD, 2013, 122 (21)
  • [6] Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Ghanem, Sassine
    Masood, Adeel
    Mohamedi, Ali H.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Rezvani, Katy
    Champlin, Richard
    Shpall, Elizabeth J.
    Lin, Pei
    Qazilbash, Muzaffar H.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [7] Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients
    Oren Pasvolsky
    Denái R. Milton
    Mikael Rauf
    Sassine Ghanem
    Adeel Masood
    Ali H. Mohamedi
    Mark R. Tanner
    Qaiser Bashir
    Samer Srour
    Neeraj Saini
    Paul Lin
    Jeremy Ramdial
    Yago Nieto
    Guilin Tang
    Hans C. Lee
    Krina K. Patel
    Partow Kebriaei
    Sheeba K. Thomas
    Donna M. Weber
    Robert Z. Orlowski
    Katy Rezvani
    Richard Champlin
    Elizabeth J. Shpall
    Pei Lin
    Muzaffar H. Qazilbash
    Blood Cancer Journal, 13
  • [8] Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
    Dave SB Hoon
    Nature Clinical Practice Oncology, 2004, 1 : 74 - 75
  • [9] Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
    Hoon, Dave S. B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 74 - 75
  • [10] Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study
    Kunacheewa, Chutima
    Lee, Hans C.
    Patel, Krina
    Thomas, Sheeba
    Amini, Behrang
    Srour, Samer
    Bashir, Qaiser
    Nieto, Yago
    Qazilbash, Muzzaffar H.
    Weber, Donna M.
    Feng, Lei
    Orlowski, Robert Z.
    Lin, Pei
    Manasanch, Elisabet E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05): : E221 - +
12345